Please assess the completion status of the following clinical trial:

Trial Title: Impact of Mitral Regurgitation on Coronary Haemodynamics and Instantaneous Effect of Transcatheter Mitral Valve Repair

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Age ≥18 years;~2. Patients with significant degenerative or functional MR planned for TMVR with the percutaneous edge-to-edge mitral valve repair MitraClip system;~3. Patients with ≥ 1 coronary artery lesion with angiographically-documented ≥50% diameter stenosis,~4. Patient willing and able to provide written informed consent.~Exclusion Criteria:~1. Previous coronary artery bypass surgery;~2. Presence of ≥1 coronary total occlusion(s);~3. Documented non-viable myocardium in the area of the corresponding coronary artery being studied;~4. Severe left ventricular systolic dysfunction (\<30%);~5. Cardiogenic shock/hemodynamic instability at the time of intervention (heart rate\<50 beats per minute, systolic blood pressure \<90mmHg) and/or need for mechanical/pharmacologic hemodynamic support;~6. Systolic pulmonary artery pressure \> 70 mmHg on baseline echocardiography;~7. Significant contraindication to adenosine administration (e.g. heart block, severe asthma);~8. Extremely calcified or tortuous vessels precluding invasive coronary physiology measurement;~9. Acute coronary syndrome with recent ST-elevation myocardial infarction \<5 days prior to randomization, or ongoing non-ST elevation acute coronary syndrome with biomarkers (cardiac troponin) still rising;~10. Hypertrophic cardiomyopathy, restrictive pericarditis, constrictive pericarditis, infiltrative cardiomyopathy;~11. Participation or planned participation in another clinical trial, except for observational registries;~12. Patients unable or unwilling to provide written informed consent

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Transcatheter Mitral Valve Repair arm (Type: EXPERIMENTAL): Patients with severe Mitral Insufficiency with concomitant intermediate coronary artery stenosis undergoing Transcatheter Mitral Valve Repair using the percutaneous edge-to-edge MitraClip system

Based on this trial design, predict the completion outcome and termination type (if applicable).